StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Piper Jaffray On Gilead (GILD) - It Stinks But If You Hold Your Nose It's Not That Bad
February 8, 2017 6:12 AM
Piper Jaffray lowered its price target on Gilead Sciences (NASDAQ: GILD) to $95.00 (from $102.00) while maintaining a Overweight rating.Analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Hot Comments
Next Articles
Gild Sciences (GILD) PT Drops to $75 at BMO on Bad Guidance
February 9, 2017 6:41 AM
Gilead Sciences (GILD): 'Acquisition Wanted! - Please Apply Within'
February 8, 2017 11:09 AM
Gilead Sciences (GILD) Pressured on Market Open, Shares Down 10%
February 8, 2017 9:40 AM
Needham & Company Remains Sidelined on Gilead Sciences (GILD) Following 4Q
February 8, 2017 6:57 AM
Gilead (GILD) PT Drops to $87 at Baird on 2017 Guidance
February 8, 2017 6:19 AM